M. Orme

Effects of Continuous Versus Cyclical Oral Contraception: A Randomized Controlled Trial

Guidelines for the Management of Spontaneous Intracerebral Hemorrhage

Guidelines for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack

2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation: Executive Summary

May mothers given warfarin breast-feed their infants?

Human P450 metabolism of warfarin

Pharmacology and Management of the Vitamin K Antagonists

Prostaglandin synthase 1 gene disruption in mice reduces arachidonic acid-induced inflammation and indomethacin-induced gastric ulceration

Vascularized and functional human liver from an iPSC-derived organ bud transplant

Assessment of Chimeric Mice with Humanized Liver as a Tool for Predicting Circulating Human Metabolites

Adverse drug reactions: definitions, diagnosis, and management

Herb-drug interactions

Severe and complicated malaria

Association Between CYP2C9 Genetic Variants and Anticoagulation-Related Outcomes During Warfarin Therapy

Oral Anticoagulant Therapy

Cushing's syndrome

Nonalcoholic Fatty Liver Disease

Glioblastoma and Other Malignant Gliomas

Antithrombotic Therapy for VTE Disease

Ratio of the R and S enantiomers of salsolinol in food and human urine

Emergency Hospitalizations for Adverse Drug Events in Older Americans

Is Liver Biopsy Useful in the Evaluation of Patients with Chronically Elevated Liver Enzymes?

The Pictet–Spengler Reaction in Nature and in Organic Chemistry

The Management of Thrombosis in the Antiphospholipid-Antibody Syndrome

Reporting of adverse drug reactions by hospital pharmacists: pilot scheme: Table 1

Clinically relevant drug interactions with antiepileptic drugs

Diagnosis and Treatment of Polycystic Ovary Syndrome: An Endocrine Society Clinical Practice Guideline

Comparative Pharmacology of Newer Progestogens

Dabigatran versus Warfarin in the Treatment of Acute Venous Thromboembolism

Development of the Alcohol Use Disorders Identification Test (AUDIT): WHO Collaborative Project on Early Detection of Persons with Harmful Alcohol Consumption‐II

Antithrombotic Therapy for VTE Disease

Risk for Serious Gastrointestinal Complications Related to Use of Nonsteroidal Anti-inflammatory Drugs

Nonsteroidal Antiinflammatory Drugs — Differences and Similarities

Mechanisms of drug combinations: interaction and network perspectives

Oral Anticoagulants

Pharmacological Importance of Stereochemical Resolution of Enantiomeric Drugs

Polycystic Ovary Syndrome

Nonsteroidal Anti-Inflammatory Drugs in Perisurgical Pain Management

Oral Anticoagulants: Mechanism of Action, Clinical Effectiveness, and Optimal Therapeutic Range

Appropriate prescribing in elderly people: how well can it be measured and optimised?

HEPATIC MICROSOMAL ENZYME INDUCTION AND ADRENAL CRISIS DUE TO o,p’DDD THERAPY FOR METASTATIC ADRENOCORTICAL CARCINOMA

Rivaroxaban versus Enoxaparin for Thromboprophylaxis after Hip Arthroplasty

Nonalcoholic fatty liver disease: A spectrum of clinical and pathological severity☆, ☆☆

Prostaglandin synthase 2 gene disruption causes severe renal pathology in the mouse

Metabolism of warfarin enantiomers in Japanese patients with heart disease having different CYP2C9 and CYP2C19 genotypes*

Appropriateness in health care: Application to prescribing

Pharmacology of estrogens and progestogens: influence of different routes of administration

The Pharmacology and Management of the Vitamin K Antagonists

Cytochrome P450 enzymes in drug metabolism: Regulation of gene expression, enzyme activities, and impact of genetic variation

NONSTEROIDAL ANTI-INFLAMMATORY DRUGS ANOTHER LOOK

A Mechanistic Approach to Antiepileptic Drug Interactions

Clopidogrel plus aspirin versus oral anticoagulation for atrial fibrillation in the Atrial fibrillation Clopidogrel Trial with Irbesartan for prevention of Vascular Events (ACTIVE W): a randomised controlled trial

The Effects of Danshen (Salvia miltiorrhiza) on Warfarin Pharmacodynamics and Pharmacokinetics of Warfarin Enantiomers in Rats

Drug−Protein Adducts:  An Industry Perspective on Minimizing the Potential for Drug Bioactivation in Drug Discovery and Development

2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation

Correlation between oral drug absorption in humans and apparent drug permeability coefficients in human intestinal epithelial (Caco-2) cells

Some Laboratory Correlates of Drinking Habits

Understanding the Dose-Effect Relationship

Developmental effects of endocrine-disrupting chemicals in wildlife and humans.

2019 AHA/ACC/HRS Focused Update of the 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation

American Heart Association/American College of Cardiology Foundation Guide to Warfarin Therapy

The Many Roles for Fluorine in Medicinal Chemistry

Guidelines for the Primary Prevention of Stroke

Guide to anticoagulant therapy. Part 2: Oral anticoagulants. American Heart Association.

2019 AHA/ACC/HRS Focused Update of the 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society in Collaboration With the Society of Thoracic Surgeons

ACC/AHA 2006 Guidelines for the Management of Patients With Valvular Heart Disease

American Heart Association/American College of Cardiology Foundation guide to warfarin therapy11The American Heart Association makes every effort to avoid any actual or potential conflicts of interest that may arise as a result of an outside relationship or a personal, professional, or business interest of a member of the writing panel. Specifically, all members of the writing group are required to complete and submit a Disclosure Questionnaire showing all such relationships that might be perceived as real or potential conflicts of interest.This statement has been co-published in the April 1, 2003, issue of Circulation.This statement was approved by the American Heart Association Science Advisory and Coordinating Committee in October 2002 and by the American College of Cardiology Board of Trustees in February 2003. A single reprint is available by calling 800-242-8721 (US only) or writing the American Heart Association, Public Information, 7272 Greenville Ave, Dallas, TX 75231-4596. Ask for reprint No. 71-0254. To purchase additional reprints: up to 999 copies, call 800-611-6083 (US only) or fax 413-665-2671; 1000 or more copies, call 410-528-4426, fax 410-528-4264, or e-mail klbradle@lww.com. To make photocopies for personal or educational use, call the Copyright Clearance Center, 978-750-8400.

Actions of Caffeine in the Brain with Special Reference to Factors That Contribute to Its Widespread Use

U.S. Medical Eligibility Criteria for Contraceptive Use, 2016

Comparative Toxicology of Chlordecone (Kepone) in Humans and Experimental Animals

Cyclooxygenase in biology and disease

2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation

2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation

Insecticide-treated bed nets and curtains for preventing malaria

Dynamic Inversion of Stereoselective Phosphate Binding to a Bisurea Receptor Controlled by Light and Heat

Narrative Review: The Promotion of Gabapentin: An Analysis of Internal Industry Documents

Hepatic microsomal drug oxidation and electron transport in newborn infants

2008 Focused Update Incorporated Into the ACC/AHA 2006 Guidelines for the Management of Patients With Valvular Heart Disease

Photopharmacology: Beyond Proof of Principle

Clinical Pharmacokinetics and Pharmacodynamics of Warfarin

Characteristics of the amiodarone–warfarin interaction during long-term follow-up

Changes in Plasma γ-Glutamyl Transpeptidase Activity Associated with Alterations in Drug Metabolism in Man

INTERINDIVIDUAL DIFFERENCES IN RATES OF DRUG OXIDATION IN MAN

Clinical pharmacology and primary health care in Europe ? a gap to bridge

The lack of interaction between temafloxacin and combined oral contraceptive steroids

The interaction of phenytoin and carbamazepine with combined oral contraceptive steroids.

Metabolism of the contraceptive steroid desogestrel by the intestinal mucosa.

Pharmacokinetics and Biochemical Effects in Responders and Non-Responders to Non-Steroidal Anti-Inflammatory Drugs

Warfarin STEREOCHEMICAL ASPECTS OF ITS METABOLISM AND THE INTERACTION WITH PHENYLBUTAZONE

The disposition of amodiaquine in Zambians and Nigerians with malaria.

Kinetics of warfarin absorption in man

The effects of ampicillin oral contraceptive steroids in women.

Pharmacokinetics and pharmacodynamics of the enantiomers of warfarin in man

Plasma concentration of phenylbutazone and its therapeutic effect‐ studies in patients with rheumatoid arthritis.

Adverse drug reactions: a hospital pharmacy‐based reporting scheme.

Urinary concentrations of steroid glucuronides in women taking oral contraceptives

The gut wall metabolism of ethinyloestradiol and its contribution to the pre‐systemic metabolism of ethinyloestradiol in humans.